Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

By Aude Bandini, Professeure agrégée, Philosophie (épistémologie et philosophie de la médecine), Université de Montréal
Jean-Philippe Drouin-Chartier, Professeur agrégé, Faculté de pharmacie, Université Laval
Pierre-Marie David, Professeur adjoint à la faculté de pharmacie, Université de Montréal
Rémi Rabasa-Lhoret, Professeur de médecine et de nutrition, Université de Montréal

We need to take stock of the promises and limitations of new “miracle” weight loss drugs such as Ozempic, Mounjaro and Wegovy.

Read complete article

~	Kenya’s femicide cases need national action: declare a crisis now – scholar

~	Champions League 2024: data suggests the new format could end up being fairer and more competitive

~	How do ecosystems collapse? Our study shows evolution plays a role – and can delay a disaster

~	Lesotho: Authorities must promptly investigate allegations that army tortured and killed civilians

~	Mass pager attack in Lebanon raises concerns over cyber warfare and terrorism

~	New teen accounts on Instagram are a welcome step, but real ‘peace of mind’ requires more

~	What’s the difference between a psychopath and a sociopath? Less than you might think

~	Digital health research can be positive for Indigenous people. But our study found it needs to follow these principles

~	Australia desperately needs a strong federal environmental protection agency. Our chances aren’t looking good

~	The Productivity Commission wants all Australian kids to get 3 days a week of childcare – but it won’t be until 2036